Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of small molecule single-agent and combination therapy candidates for the treatment of chronic liver diseases, such as non-alcoholic steatohepatitis (NASH), and oncology. Their pipeline includes candidates targeting key pathways involved in these diseases, aiming to bring innovative therapies to patients with significant unmet medical needs. Terns leverages internal expertise and strategic collaborations to advance its programs.
The headquarters serves as the central hub for corporate operations, research and development oversight, clinical development strategy, business development, and administrative functions.
The facility is a modern office and lab-supporting space, designed to foster collaboration and innovation among its scientific and corporate teams. It is situated in a biotech-focused campus environment.
The work culture at Terns Pharmaceuticals emphasizes scientific rigor, innovation, collaboration, and a patient-centric approach. Employees are driven by the mission to develop impactful therapies for serious diseases.
Its location in the San Francisco Bay Area provides access to a rich ecosystem of talent, research institutions, and potential partners, crucial for a clinical-stage biopharmaceutical company.
Terns Pharmaceuticals operates with a strategic global footprint, anchored by its headquarters in California, USA, and a significant research and development presence in Shanghai, China. This dual presence allows the company to leverage scientific talent and resources in key biotechnology hubs. Furthermore, Terns conducts clinical trials for its drug candidates in multiple countries, reflecting a global approach to drug development and patient access.
1065 East Hillsdale Blvd, Suite 100
Foster City
CA
USA
Address: Building 1, 333 Qinjiang Road, Xuhui District, Shanghai, China (Representative Office/R&D Center)
To expand Terns' R&D capabilities, accelerate drug discovery and development programs, and facilitate clinical trial activities and potential collaborations within China and the broader Asian market.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Terns Pharmaceuticals' leadership includes:
Terns Pharmaceuticals has been backed by several prominent investors over the years, including:
In the past 12 months, Terns Pharmaceuticals has made strategic appointments to strengthen its leadership team, particularly in business and clinical development roles.
Discover the tools Terns Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Terns Pharmaceuticals primarily uses the [first_initial][last]@ternspharma.com email format. This is a common structure for many companies in the biopharmaceutical industry.
[first_initial][last]@ternspharma.com
Format
jsundaram@ternspharma.com
Example
85%
Success rate
GlobeNewswire • May 9, 2024
Terns Pharmaceuticals announced its Q1 2024 financial results, highlighting progress in its clinical programs, including TERN-701 for CML and TERN-501 for NASH. The company outlined upcoming milestones and its financial position....more
GlobeNewswire • April 8, 2024
Terns Pharmaceuticals presented promising preclinical and Phase 1 clinical trial initiation data for TERN-701, an allosteric BCR-ABL inhibitor for chronic myeloid leukemia (CML), at the American Association for Cancer Research (AACR) Annual Meeting 2024....more
GlobeNewswire • November 2, 2023
Terns announced the appointment of Bryan Yoon as Chief Business Officer and General Counsel, and the promotion of Emil Kuriakose, M.D., to Chief Medical Officer, bolstering its executive team to support company growth and pipeline advancement....more
GlobeNewswire • June 21, 2023
Terns reported positive topline results from its Phase 2a DUET trial, showing that TERN-501, a THR-β agonist, demonstrated statistically significant and clinically meaningful liver fat reduction and favorable tolerability in NASH patients, both as monotherapy and in combination....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Terns Pharmaceuticals, are just a search away.